[1] Holloway KA, Henry D.WHO essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveys[J].PLoS Med, 2014, 11(9): e1001724 [2] Tian X, Song Y, Zhang X.National Essential Medicines List and policy practice: a case study of China's health care reform[J].Bmc Health Serv Res, 2012, 12: 401 [3] 李幼平, 沈建通.基本药物目录遴选与使用的发展与创新[J].中国循证医学杂志, 2013, v.13;No.130(11): 1273 [4] 郭莹, 甘露, 邢花,等.浅析国外基本药物目录遴选的成功经验[J].中国药事, 2013, v.27(04): 353 [5] 李远, 黄玺.我国基本药物遴选原则及遴选方法浅析[J].中国药房, 2013, v.24;No.426(12): 1057 [6] The selection and use of essential medicines[J].World Health Organ Tech Rep Ser, 2014(985): 1 [7] 肖宏浩, 郭振华, 饶晓兵.澳大利亚的经验对我国基本药物目录遴选的启示[J].中国药事, 2008(11): 961 [8] Chongtrakul P, Sum N, Yoongthong W.泰国选择基本药物的循证方法和ISafE[J].中国执业药师, 2009, v.6(04): 46 [9] Teerawattananon Y, Tritasavit N, Suchonwanich N,等.The use of economic evaluation for guiding the pharmaceutical reimbursement list in Thailand[J].Z Evid Fortbild Qual Gesundhwes, 2014, 108(7): 397 [10] 曾宪涛, 黄伟, 田国祥.Meta分析系列之九:Meta分析的质量评价工具[J].中国循证心血管医学杂志, 2013, v.5(01): 3 [11] 王靖, 刘琴, 翁淳光,等.国内公共卫生研究领域系统评价/Meta分析的质量评价[J].中国循证医学杂志, 2010, v.10;No.95(12): 1367 [12] 尹森林, 刘雪梅, 何林,等.对系统评价/Meta分析报告规范的系统评价[J].中国循证医学杂志, 2011, v.11;No.103(08): 971 [13] Curtiss FR.Quality of Health Economic Studies (QHES)--tool or mask?[J].J Manag Care Pharm, 2003, 9(1): 93 [14] Motheral B.Assessing the value of the Quality of Health Economic Studies (QHES)[J].J Manag Care Pharm, 2003, 9(1): 86
|